ELVNEnliven Therapeutics, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $39.07 (+0.59% today)

Market Cap: $2.32B

P/E (TTM): -21.20

Relative Strength (RS%): 54

-3.8% from 52-week high

Back to Scanner

ELVN

NASDAQRS 54Score 38

Enliven Therapeutics, Inc.

HealthcareBiotechnology$2.32B1 setup passing
$39.07
+0.6% ($0.23)
-3.8% from 52W High
P/E (TTM)
-21.20
Fwd P/E
PEG
Analyst Upside
EPS Growth
Gross Margin
0.0%
ROE
-24.2%
D/E
0.00
Div Yield
0.0%
Avg Volume
810.9K

Price Chart

Key Levels

SMA 200
$22.61
SMA 50
$29.46
Price
$39.07
52W High
$40.61

Setup Radar

1/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst